TY  - GEN
AU  - Betts,Keith A
AU  - Griffith,Jenny
AU  - Friedman,Alan
AU  - Zhou,Zheng-Yi
AU  - Signorovitch,James E
AU  - Ganguli,Arijit
TI  - An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritis
SN  - 1473-4877
PY  - 2016///1213
KW  - Adalimumab
KW  - administration & dosage
KW  - Antirheumatic Agents
KW  - Arthritis, Psoriatic
KW  - drug therapy
KW  - Bayes Theorem
KW  - Biological Products
KW  - Clinical Trials, Phase III as Topic
KW  - Comparative Effectiveness Research
KW  - Costs and Cost Analysis
KW  - Health Care Costs
KW  - Humans
KW  - Methotrexate
KW  - Models, Economic
KW  - Network Meta-Analysis
KW  - Randomized Controlled Trials as Topic
KW  - Thalidomide
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
UR  - https://doi.org/10.1185/03007995.2016.1140026
ER  -